Details for Accession #: Q8TEQ6


Protein Sequence










Peptide Information

ID Peptide Seq Site Residue Position in Peptide Position in Protein
10002738 616
10002961 616
10005387 TVIESSPESPVTITEPYR T 1 616
10011742 NNAVIYVHNLKTVIESSPESPVTITEPYRTL S 620
10011743 LAPAVSREPVICTPVSSGFEKSKVTINNKVI S 810
10021355 620
10022951 TVIESSPESPVTITEPYR T 2 616
10023835 TVIESSPESPVTITEPYR S 5 620
10024945 EPVICTPVSSGFEK S 9 810
10024946 TVIESSPESPVTITEPYR S 9 624
10025338 TVIESSPESPVTITEPYR T 1 616
10027841 EPVICTPVSSGFEK T 6 807
10028307 TVIESSPESPVTITEPYR T 1 616
10030123 T 616
10037326 TVIESSPESPVTITEPYR 616
10037527 TVIESSPESPVTITEPYR 616
10037528 TVIESSPESPVTITEPYR 620

O-GlcNAcylation Information

ID Method Analytical Throughput Ambiguity Species Sample Type Condition log2Ratio P Value Data Source PMID Comments
10002738 MS HTP unambiguous human HeLa cells Mitotic exit/Early mitosis 100 34161081 The p value was -log10p in original paper.
10002961 MS HTP unambiguous human colorectal cancer (CRC) cell lines SW620 cells/SW480 cells -0.839959587 0.00087121 35254053
10005387 MS HTP unambiguous human HEK 293T cells glucose-deprived/glucose-sufficient 0.65 37541260
10011742 MS HTP unambiguous human HeLa cells 30059200
10011743 MS HTP unambiguous human HeLa cells 30059200
10021355 MS HTP unambiguous human HeLa cells 34161081
10022951 MS HTP unambiguous human HeLa cells 34846842
10023835 MS HTP unambiguous human THP1 cells 32938750
10024945 MS HTP unambiguous human Jurkat cells, MCF-7 cells, K562 cells 35132862
10024946 MS HTP unambiguous human Jurkat cells, MCF-7 cells, K562 cells 35132862
10025338 MS HTP unambiguous human HeLa cells 35254053
10027841 MS HTP unambiguous human HeLa cells 35254053
10028307 MS HTP unambiguous human SW480 cells 35254053
10030123 MS HTP unambiguous human SW480 cells, SW620 cells SW620/SW480 -0.839959587 8.71E-04 35254053
10037326 MS HTP unambiguous human HEK 293T cells TMG/control -0.321928095 30620550 Peptide quantification value was applied to each modification site
10037527 MS HTP unambiguous human HepG2 cells orafenib sensitive/resistant -1.736965594 30620550 Peptide quantification value was applied to each modification site
10037528 MS HTP unambiguous human HepG2 cells orafenib sensitive/resistant -1.736965594 30620550 Peptide quantification value was applied to each modification site

ID Peptide Seq Site Residue Position in Peptide Position in Protein Method Analytical Throughput Ambiguity Species Sample Type Data Source PMID Comments
10002738 616 MS HTP unambiguous human HeLa cells 34161081 The p value was -log10p in original paper.
10002961 616 MS HTP unambiguous human colorectal cancer (CRC) cell lines 35254053
10005387 TVIESSPESPVTITEPYR T 1 616 MS HTP unambiguous human HEK 293T cells 37541260
10011742 NNAVIYVHNLKTVIESSPESPVTITEPYRTL S 620 MS HTP unambiguous human HeLa cells 30059200
10011743 LAPAVSREPVICTPVSSGFEKSKVTINNKVI S 810 MS HTP unambiguous human HeLa cells 30059200
10021355 620 MS HTP unambiguous human HeLa cells 34161081
10022951 TVIESSPESPVTITEPYR T 2 616 MS HTP unambiguous human HeLa cells 34846842
10023835 TVIESSPESPVTITEPYR S 5 620 MS HTP unambiguous human THP1 cells 32938750
10024945 EPVICTPVSSGFEK S 9 810 MS HTP unambiguous human Jurkat cells, MCF-7 cells, K562 cells 35132862
10024946 TVIESSPESPVTITEPYR S 9 624 MS HTP unambiguous human Jurkat cells, MCF-7 cells, K562 cells 35132862
10025338 TVIESSPESPVTITEPYR T 1 616 MS HTP unambiguous human HeLa cells 35254053
10027841 EPVICTPVSSGFEK T 6 807 MS HTP unambiguous human HeLa cells 35254053
10028307 TVIESSPESPVTITEPYR T 1 616 MS HTP unambiguous human SW480 cells 35254053
10030123 T 616 MS HTP unambiguous human SW480 cells, SW620 cells 35254053
10037326 TVIESSPESPVTITEPYR 616 MS HTP unambiguous human HEK 293T cells 30620550 Peptide quantification value was applied to each modification site
10037527 TVIESSPESPVTITEPYR 616 MS HTP unambiguous human HepG2 cells 30620550 Peptide quantification value was applied to each modification site
10037528 TVIESSPESPVTITEPYR 620 MS HTP unambiguous human HepG2 cells 30620550 Peptide quantification value was applied to each modification site